Arrowhead Pharmaceuticals, Inc.

AMERIPRISE FINANCIAL INC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

257,477

Value ($000)

17,094

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	17,094	0.0%	257,477	12/31/2025
2025 Q3	11/14/2025	9,456	0.0%	274,163	9/30/2025
2025 Q2	8/14/2025	4,219	0.0%	267,027	6/30/2025
2025 Q1	5/14/2025	3,647	0.0%	286,231	3/31/2025
2024 Q4	2/14/2025	4,230	0.0%	224,988	12/31/2024
2024 Q3	11/14/2024	4,247	0.0%	219,256	9/30/2024
2024 Q2	8/14/2024	19,186	0.0%	738,200	6/30/2024
2024 Q1	5/15/2024	28,523	0.0%	997,297	3/31/2024
2023 Q4	2/14/2024	28,415	0.0%	928,600	12/31/2023
2023 Q3	11/14/2023	18,637	0.0%	693,616	9/30/2023
2023 Q2	8/14/2023	16,095	0.0%	451,339	6/30/2023
2023 Q1	5/22/2023	11,843	0.0%	466,278	3/31/2023
2022 Q4	2/14/2023	20,509	0.0%	505,635	12/31/2022
2022 Q3	11/14/2022	17,543	0.0%	530,773	9/30/2022
2022 Q2	8/15/2022	18,951	0.0%	538,233	6/30/2022
2022 Q1	5/16/2022	24,656	0.0%	536,131	3/31/2022
2021 Q4	2/14/2022	36,078	0.0%	544,172	12/31/2021
2021 Q3	11/15/2021	30,977	0.0%	496,197	9/30/2021
2021 Q2	8/16/2021	41,256	0.0%	498,163	6/30/2021
2021 Q1	5/17/2021	32,711	0.0%	493,306	3/31/2021
2020 Q4	2/12/2021	36,501	0.0%	475,682	12/31/2020
2020 Q3	11/16/2020	22,998	0.0%	534,059	9/30/2020
2020 Q2	8/14/2020	18,864	0.0%	436,698	6/30/2020
2020 Q1	5/15/2020	9,930	0.0%	345,165	3/31/2020
2019 Q4	2/14/2020	22,926	0.0%	361,434	12/31/2019